Tuberculosis

Introducing fast and accurate tests where patients seek care

 

Malaria & Acute febrile syndrome (AFS)

Assuring quality of existing rapid tests and developing new tools

Neglected tropical diseases (NTDs)

Contributing to elimination through new and improved tests

Ebola

Partnering to deliver the right tools to the right places

Access

Laboratory strengthening and training

  • 1
  • 2
  • 3
  • 4
  • 5

Latest News

Summary from meeting on diagnostic needs for Plasmodium vivax malaria

28 January 2016

The executive summary of the final report of a meeting convened by FIND on diagnostic needs for Plasmodium vivax is now available. Attendees of the meeting, held on 25 Oct. 2015 in Philadelphia, reviewed draft target product profiles for more sensitive P. vivax diagnostic tests, which are urgently needed. Currently, available tests prevent the detection of up to 70% of all P. vivax infections.

FIND signs partnership agreement with McGill on TB diagnostics

28 January 2016

FIND is pleased to announce the finalization of a memorandum of understanding with the Research Institute of the McGill University Health Centre in Montreal, with a focus on tuberculosis (TB) diagnostics.

Experts conclude interim results look good for second-generation HAT RDT

27 January 2016

Interim results look promising in a clinical trial evaluating the prototype second-generation rapid diagnostic test (RDT) for sleeping sickness, according to a group of experts that met at FIND on 14 January 2016.

REMINDER: Jan. 31 deadline for trial proposals to evaluate Cepheid GeneXpert Omni with new TB assay

18 January 2016

FIND invites expressions of interest for trials to demonstrate the performance and impact of the new Cepheid GeneXpert®Omni system in combination with the new Xpert® MTB/RIF Ultra assay for detection of TB and rifampicin resistance. The deadline is Jan. 31.

right column